This inventor holds 1 USPTO granted patent. Top assignee: Temple University. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: The Innovative Contributions of Dulce C Veloso
Introduction
Dulce C Veloso is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. Her work has implications for diagnostics and therapeutic applications.
Latest Patents
Dulce C Veloso holds a patent for "Monoclonal antibodies to human plasma prekallikrein." This patent includes four novel cell lines, ATCC #HB-8862 through ATCC #HB-8865, which produce monoclonal antibodies targeting human plasma prekallikrein. Notably, at least three of these antibodies also recognize plasma kallikrein, specifically the heavy chain and kallikrein-Cl-inhibitor complex. Additionally, at least one of these antibodies recognizes the kallikrein-alpha.sub.2-macroglobulin complex and the kallikrein-antithrombin III complex. Importantly, these antibodies do not cross-react with tissue kallikrein. The hybridomas are formed by fusing spleen cells from immunized BALB/c AnSkh mice with SP2/O-Agl4 myeloma cells. The diagnostic and biochemical uses of these monoclonal antibodies are also provided in her patent.
Career Highlights
Dulce C Veloso is affiliated with Temple University, where she conducts her research and development work. Her innovative approach and dedication to her field have led to advancements in the understanding and application of monoclonal antibodies.
Collaborations
Dulce collaborates with Robert W Colman, contributing to the advancement of their shared research interests.
Conclusion
Dulce C Veloso's work in developing monoclonal antibodies represents a significant advancement in biomedical research. Her contributions continue to impact the field positively.